You have 9 free searches left this month | for more free features.

Pomalidomide-dexamethasone

Showing 1 - 25 of 2,305

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma Trial in Beijing, Qingdao (SPD:Selinexor Oral Tablet, Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • SPD:Selinexor Oral Tablet, Pomalidomide, Dexamethasone
  • Beijing, Beijing, China
  • +1 more
Jul 26, 2022

Multiple Myeloma Trial (Elranatamab, Elotuzumab, Pomalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Nov 28, 2023

Multiple Myeloma Trial in Hackensack (Daratumumab, Pomalidomide, All-trans retinoic acid)

Recruiting
  • Multiple Myeloma
  • Hackensack, New Jersey
    John Theurer Cancer Center
Jun 10, 2022

Multiple Myeloma in Relapse, Refractory Multiple Myeloma Trial in Israel (ixazomib-pomalidomide-dexamethasone)

Recruiting
  • Multiple Myeloma in Relapse
  • Refractory Multiple Myeloma
  • Afula, Israel
  • +7 more
Jul 10, 2022

Multiple Myeloma, Relapse Multiple Myeloma Trial in Chicago (Belantamab mafodotin, Carfilzomib, Pomalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Relapse Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Chicago, Illinois
    University of Chicago Medicine Comprehensive Cancer Center
Mar 23, 2023

Multiple Myeloma Trial in Seoul (Carfilzomib 56 MG [Kyprolis], Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Carfilzomib 56 MG [Kyprolis]
  • +2 more
  • Seoul, Korea, Republic of
    Samsung Medical Center
Aug 19, 2022

Multiple Myeloma, Refractory Multiple Myeloma, Relapse Multiple Myeloma Trial in New York (Daratumumab, Clarithromycin,

Recruiting
  • Multiple Myeloma
  • +2 more
  • New York, New York
    Weill Cornell Medicine - Multiple Myeloma Center
Jun 8, 2022

Relapsed Cancer, Refractory Multiple Myeloma, Multiple Myeloma Trial in Boston (Isatuximab, Belantamab mafodotin, Pomalidomide)

Not yet recruiting
  • Relapsed Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jun 19, 2023

Multiple Myeloma, Relapse, Refractory Trial in Chapel Hill, Winston-Salem, Columbus (Isatuximab, Pomalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • +4 more
  • Chapel Hill, North Carolina
  • +2 more
Jun 9, 2023

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial in Poitiers (Isatuximab, Carfilzomib, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • Poitiers, France
    CHU Poitiers
Jan 9, 2023

Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in Canada, United States (pomalidomide, bortezomib,

Active, not recruiting
  • Light Chain Deposition Disease
  • Primary Systemic Amyloidosis
  • Denver, Colorado
  • +4 more
Jan 20, 2023

Multiple Myeloma Trial in Duarte, Boston, Portland (SL-401/ Pomalidomide/ Dexamethasone)

Terminated
  • Multiple Myeloma
  • SL-401/ Pomalidomide/ Dexamethasone
  • Duarte, California
  • +2 more
Jan 13, 2022

Multiple Myeloma, Refractory Multiple Myeloma, Multiple Myeloma in Relapse Trial in Boston (Daratumumab, Carfilzomib,

Recruiting
  • Multiple Myeloma
  • +3 more
  • Boston, Massachusetts
  • +2 more
Oct 28, 2021

Multiple Myeloma Trial (Daratumumab, Cyclophosphamide, Pomalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 8, 2021

Relapsed Refractory Multiple Myeloma Trial (REGN5458, Elotuzumab, Pomalidomide)

Not yet recruiting
  • Relapsed Refractory Multiple Myeloma
  • (no location specified)
Feb 6, 2023

Plasma Cell Myeloma Trial in Atlanta (Belantamab Mafodotin, Dexamethasone, Pomalidomide)

Recruiting
  • Plasma Cell Myeloma
  • Belantamab Mafodotin
  • +2 more
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Jul 21, 2022

Multiple Myeloma Trial in Canada, United States (Pomalidomide, Carfilzomib, dexamethasone)

Recruiting
  • Multiple Myeloma
  • Chicago, Illinois
  • +4 more
Jan 7, 2022

Multiple Myeloma, Multiple Myeloma in Relapse Trial in Boston (Ixazomib, Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Multiple Myeloma in Relapse
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Apr 13, 2022

Multiple Myeloma Trial in United States (Pomalidomide, stem cell, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +9 more
Jan 23, 2023

Multiple Myeloma Trial in United States (Carfilzomib, Pomalidomide, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Atlanta, Georgia
  • +8 more
Jul 28, 2022

Non-interventional Study With Pomalidomide (Imnovid®)

Completed
  • Multiple Myeloma
    • Freiburg, Baden-Wuerttemberg, Germany
      iOMEDICO AG
    Aug 11, 2022

    Plasma Cell Leukemia, Plasma Cell Myeloma, Plasmacytoma Trial in Rochester, Nashville (Dexamethasone, Ixazomib Citrate,

    Active, not recruiting
    • Plasma Cell Leukemia
    • +2 more
    • Rochester, Minnesota
    • +1 more
    May 19, 2022

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (Carfilzomib, Dexamethasone, Isatuximab)

    Recruiting
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 16, 2022

    Myeloma Trial in La Jolla, Orange, Sacramento (Clarithromycin, Dexamethasone, Ixazomib Citrate)

    Active, not recruiting
    • Myeloma
    • La Jolla, California
    • +2 more
    Mar 14, 2022